Edition:
United States

Biotechnology & Medical Research

Verastem Announces Pricing Of Public Offering Of Common Stock

Verastem Inc ::VERASTEM ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.VERASTEM INC - ANNOUNCED PRICING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF APPROXIMATELY $25 MILLION OF SHARES OF ITS COMMON STOCK.

9:18am EST

Global Blood Therapeutics Prices A $100.0 Mln Common Stock Public Offering

Dec 15 (Reuters) - Global Blood Therapeutics Inc ::GLOBAL BLOOD THERAPEUTICS PRICES A $100.0 MILLION COMMON STOCK PUBLIC OFFERING.

9:03am EST

Ultragenyx And Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion For Treatment Of X-Linked Hypophosphatemia In Children

Dec 15 (Reuters) - Ultragenyx Pharmaceutical Inc ::ULTRAGENYX AND KYOWA KIRIN ANNOUNCE BUROSUMAB RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA IN CHILDREN.ULTRAGENYX PHARMA SAYS CHMP'S OPINION IS BEING REFERRED TO EC, FOR FINAL DECISION ON GRANT OF CONDITIONAL...

8:30am EST

Ibex Reports 2018 Q1 Earnings Per Share C$0.01

Dec 15 (Reuters) - Ibex Technologies Inc ::IBEX REPORTS FIRST QUARTER FISCAL 2018 RESULTS.Q1 REVENUE C$1.183 MILLION VERSUS C$1.211 MILLION.QTRLY EARNINGS PER SHARE C$0.01.IN FISCAL 2018 WE EXPECT TO SEE LOWER SALES THAN IN FISCAL 2017."WE DO NOT EXPECT ANY MAJOR CAPITAL EXPENDITURES IN FISCAL...

8:00am EST

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.